- Home
- Services
- usa washington
- oncology
Oncology Services In Washington
8 services found
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Including Pharmacokinetics and Immunogenicity. Designed to be an extension of your laboratory, Nexelis, a Q² Solutions Company, supports bioanalysis in all phases with agile assay development to validation mindset. Whether we design a custom bioanalytical assay or support a client’s technology transfer, our method development process results in an optimized assay compliant with global ...
by:Avaden Biosciences, Inc. based inSeattle, WASHINGTON (USA)
Over 350 Clinical Data Points: Pathology (Dx), oncology (treatment), radiology (imaging), internal medicine (labs), other ...
by:Nautilus Biotechnology based inSeattle, WASHINGTON (USA)
We are now providing access to our technology for a select group of collaborators. Currently, we are exploring research across a wide range of fields, including oncology, neuroscience, infectious disease, immunology, and cardiology. Our Applications Team will work closely with you to define impactful projects and provide cross-functional expertise in molecular biology, protein ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
For R&D in Immunogenicity, Immuno-Oncology, and Cell and Gene Therapy. We have exceptional in vitro bioassay development services and support for early evaluation and screening of candidate therapeutics. Our highly experienced team will facilitate in silico immunogenicity assessment with epitope prediction to in vitro immunogenicity and immuno-functionality assays. ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, cardiovascular, metabolic (NASH/NAFLD) and infectious diseases. Our scientists approach your projects with flexible and creative solutions, developing ...
by:AVM Biotechnology based inSeattle, WASHINGTON (USA)
AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells have unique properties and appear rapidly in the blood following a single dose of AVM0703. They home to abnormal cells including cancer, infected cells and autoreactive lymphocytes. It is clear that these cells could ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
From Fit-for-Purpose Development to Qualified and Validated Clinical Assays. Nexelis, a Q² Solutions Company, is a leading partner in assay development and technology transfer, with scientific discipline, critical thinking, and agility. Fit-for-purpose assay development on a wide variety of platforms support your small molecule, large molecule, or vaccine program through all phases of ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Custom Assay Development to Advance Molecules. You need reliable approaches to support what’s next in your development programs whether they are complex small molecules, advanced biologics, or vaccines. At Nexelis, a Q² Solutions Company, we break down barriers to translational research through innovation and collaboration, helping you deliver better treatments to more patients, ...